Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients

by Hassan Abolghasemi, MD, Yunes Panahi, PhD, Minoo. Ahmadinejad, MD, Gholamreza Toogeh, MD, Mehran Karimi, MD, Aziz Eghbali, MD, Nargess Bigom Mirbehbahani, MD, Bighan Keikhaei Dehdezi, MD, Zahra Badiee, MD, Hamid Hoorfar, MD, Peyman Eshghi, MD, Nader Maghsoudi, PhD, Amirhossein Sahebkar, PhD, Mohammad Gholami- Fesharaki, PhD
Published 2018-06-01